Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.
- Published in:
- Acta Neuropathologica Communications, 2018, v. 6, p. 1, doi. 10.1186/s40478-017-0506-9
- By:
- Publication type:
- Article